← Kembali ke Beranda
⚡ AMP Version

Unitedhealth Is Targeting 13% To 16% Long-term Earnings G…

Oleh Patinko •

AccessibilityHelp

▲ S&P 500 +—%|▲ Stock Advisor +—%Join The Motley Fool

Arrow down

S&P 500

7,340.53

-1.0%

-76.06

Arrow down

DJI

50,759.42

-1.6%

-848.75

Arrow down

NASDAQ

24,328.38

-0.7%

-181.37

Arrow up

Bitcoin

$64,680.00

+0.0%

+$30.59

Arrow up

SPCX

$141.70

+3.2%

+$4.34

Arrow down

AAPL

$351.91

-0.2%

-$0.87

Arrow up

AMZN

$257.89

+0.1%

+$0.14

Arrow down

GOOG

$277.60

-1.3%

-$3.66

Arrow down

META

$618.87

-1.2%

-$7.54

Arrow down

MSFT

$506.24

-2.3%

-$11.75

Arrow down

NVDA

$155.46

-0.4%

-$0.68

Arrow up

TSLA

$380.11

+0.1%

+$0.37

Free ArticleExplore Premium Services

By Rick Orford – Nov 18, 2026 at 2:00AM EST

+Fool.comon

Key Points

  • UnitedHealth’s third-quarter earnings from operations rose, and management raised its 2026 adjusted earnings outlook.

  • Optum generated big third-quarter revenue and serves over 120 million patients and consumers, giving UnitedHealth growth exposure beyond insurance.

  • Three 2031 scenarios for UnitedHealth assume annual earnings growth of between 8% and 16%, including management’s long-term target range.

UnitedHealth’s turnaround could set the stage for years of earnings growth

These days, UnitedHealth is showing signs that its turnaround strategy is working. Indeed, after a difficult stretch marked by rising medical costs, operational challenges, and pressure on profitability, the healthcare giant is making progress in improving its earnings growth.

For example, in the third quarter of 2026, revenue reached $112.7 billion, while adjusted earnings came in at $4.69 per , beating analyst expectations. More importantly, operating earnings increased to $6.6 billion from $4.3 billion year over year. On top of that, management raised its full-year 2026 adjusted earnings guidance to at least $20.50 per .

UNH – UnitedHealth Group

$389.68-$22.34 (-5.42%)

NYSE · As of 4:00 PM ET 11/17/26

Premium Feature

Moneyball Superscore71/100

Key data points

Market capMarket cap calculated using publicly traded s outstanding only. Does not include unlisted, private, or dual-class non-traded s. Implied market cap may vary.$349.16B

Day’s range$387.14 – $399.99

52wk range$255.97 – $461.62

Volume8M

Avg volume5.3M

Dividend yield2.32%

Perhaps the most interesting development for long-term investors came during the company’s October earnings call. Specifically, the company reiterated its long-term earnings growth target of 13% to 16%, adding that management considers the lower end of that range a reasonable starting point for 2027.

That means, if management can deliver on those targets, earnings could compound significantly over the next five years, giving the stock considerable upside.

Optum is becoming a key growth catalyst

One reason to be optimistic about UnitedHealth’s longer-term growth is its Optum business, which provides exposure to far more than traditional health insurance.

Specifically, Optum combines healthcare delivery, pharmacy services, and data analytics, creating several opportunities to generate revenue across different parts of the healthcare system while helping UnitedHealth manage costs within its insurance operations.

Meanwhile, Optum Health provides exposure to value-based care. Instead of charging for individual medical procedures, this model focuses on managing patients’ overall health outcomes while controlling the total cost of care. In turn, that creates an opportunity for UnitedHealth to benefit from more efficient healthcare delivery and improved patient outcomes.

Plus, Optum Insight offers attractive opportunities through its healthcare technology and data capabilities, using artificial intelligence (AI) and automation to unlock further growth. In fact, management noted that AI-enabled chart summarization had expanded to more than 40% of employed clinicians, reducing chart review time by around 33%.

Despite the improving outlook, the company still faces meaningful risks. For one, medical costs could continue to rise, especially for senior and complex patients, making it harder to improve margins. Plus, the company is exposed to changes in Medicare Advantage reimbursement, regulatory scrutiny, and pressure on its pharmacy benefit management operations.

Ultimately, UnitedHealth’s ability to turn improvements into consistent earnings growth will determine just how much upside the stock has over the next five years.

Where could UnitedHealth stock be in five years?

Management’s long-term earnings growth target of 13% to 16% is a useful starting point. Using its 2026 adjusted earnings per (EPS) guidance of $20.50, UnitedHealth could grow earnings to around $37.77 per by 2031 under the base case, assuming 13% annual growth. If it achieves the upper end of its target, EPS could reach around $43.06.

Right now, UnitedHealth trades at a forward price-to-earnings (P/E) ratio of about 17. From there, if P/E grows modestly to about 18.5 times under the base case, the target price could reach $699, suggesting the stock could increase 71.5%.

Conservatively, 8% annual growth would lift EPS to around $30.12 by 2031, and a P/E of 14 would imply $422, or 3.5% upside.

Finally, under the bull case, its P/E could expand to 22 times, pushing the target price to $947, implying a potential upside of 132.4%.

Perhaps a higher valuation could be justified if Optum continues to expand its higher-value healthcare services and technology operations, AI investments drive productivity gains, and Medicare Advantage continues to see earnings recovery.

Scenario Annual earnings growth 2031 EPS 2031 P/E Target price Upside vs. last close
Conservative 8% Around $30.12 14 $422 3.5%
Base 13% Around $37.77 18.5 $699 71.5%
Bull (optimistic) 16% Around $43.06 22 $947 132.4%

Data source: Calculations by the author.

Of course, these are scenarios, not promises, so where the stock lands by 2031 could differ. But together, the catalysts could convince investors that UnitedHealth deserves a higher valuation than a traditional health insurer does.

Where to invest $1,000 right now

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 802%* — a market-crushing outperformance compared to 205% for the S&P 500.

They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.

See the stocks ›

*Stock Advisor returns as of November 18, 2026.

Read Next

•By Rick Orford

UnitedHealth Keeps Raising Guidance. Here’s What a $10,000 Investment Could Be Worth if the Turnaround Sticks.

•By Lyle Daly

How to Invest in Vanguard Health Care ETF (VHT)

•By Parkev Tatevosian, CFA

Is it Too Late to Buy UnitedHealth Stock?

•By Rick Orford

UnitedHealth Just Raised Guidance for the Third Time This Year. Where Will the Stock Be in 3 Years?

•By Lyle Daly

The Largest Healthcare Companies by Market Cap in November 2026

•By Brendan Coffey

Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?

About the Author

Rick is a Wall Street Journal best-selling author with over 20 years of experience trading stocks and options. The most authoritative publications, including Good Morning America, Washington Post, Yahoo Finance, MSN, Business Insider, NBC, FOX, CBS, and ABC News, cover his work. His passion is business, and he works tirelessly to deliver content in an easy-to-understand manner. In 2018, Rick wrote The Financially Independent Millennial to inspire his readers with his story about becoming financially independent at age 35 despite not learning about money when he was younger. His books are easy to read and often refer to key points that “He would tell his younger self.” When not thinking about business, Rick writes (mainly about cruise ship travel) for his travel blog and is an enthusiast of fast cars, technology, & cooking.

CMFrickorford

Stocks Mentioned

UnitedHealth Group

NYSE: UNH

$389.68

(-5.42%)-$22.34

Motley Fool Stock Advisor’s Latest Pick

Get Access

—% Avg Return

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services.

View Premium Services

Sumber Artikel:

Fool.com

Baca Artikel Lengkap di Sumber